Core Laboratories Inc. $CLB Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC decreased its position in Core Laboratories Inc. (NYSE:CLB) by 5.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 824,579 shares of the oil and gas company’s stock after selling 43,147 shares during the period. Fisher Asset Management LLC owned approximately 1.77% of Core Laboratories worth $10,192,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Core Laboratories by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock worth $418,000 after purchasing an additional 1,170 shares during the last quarter. Envestnet Asset Management Inc. raised its stake in shares of Core Laboratories by 11.4% during the 2nd quarter. Envestnet Asset Management Inc. now owns 282,871 shares of the oil and gas company’s stock valued at $3,259,000 after buying an additional 28,866 shares during the last quarter. Assetmark Inc. lifted its holdings in shares of Core Laboratories by 160.8% in the 2nd quarter. Assetmark Inc. now owns 7,530 shares of the oil and gas company’s stock valued at $87,000 after buying an additional 4,643 shares during the period. Moors & Cabot Inc. boosted its stake in shares of Core Laboratories by 5.3% in the second quarter. Moors & Cabot Inc. now owns 73,954 shares of the oil and gas company’s stock worth $852,000 after buying an additional 3,695 shares during the last quarter. Finally, Fox Run Management L.L.C. acquired a new stake in Core Laboratories during the second quarter worth about $202,000. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Price Performance

Shares of Core Laboratories stock opened at $16.51 on Thursday. The stock has a market capitalization of $768.71 million, a P/E ratio of 24.64, a PEG ratio of 14.73 and a beta of 1.10. The business has a 50 day simple moving average of $18.36 and a two-hundred day simple moving average of $15.40. Core Laboratories Inc. has a 12 month low of $9.72 and a 12 month high of $20.36. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.07 and a quick ratio of 1.57.

Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. Core Laboratories had a net margin of 6.04% and a return on equity of 12.09%. The business had revenue of $138.26 million during the quarter, compared to analyst estimates of $130.40 million. During the same quarter in the prior year, the firm earned $0.22 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. As a group, analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 9th. Shareholders of record on Monday, February 16th will be paid a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, February 13th. Core Laboratories’s dividend payout ratio is currently 5.97%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Core Laboratories in a report on Monday, December 29th. Four research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $12.50.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.